All stock lists
Coca-Cola Consolidated, Inc. (NASDAQ:COKE)
US · Delayed Price · Currency is USD
Also listed: 0I0T.LConsumer Defensive · Beverages - Non-Alcoholic
208.16+4.85 (+2.38%)
Market cap
$13.9B
Health Score
Analyst consensus
Listed since
Jun 23, 1990
Website
Insider Score
––Not scored
COKE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From COKE’s reported statements · Q3 2026 (trailing 12 months)
Profitability14 / 20
Profitable, but on a thin margin.
- Revenue
- $7.69B
- Net income
- $550.0M
- Net margin
- 7.2%
Leverage9 / 20
A manageable debt load.
- Total debt
- $2.62B
- Cash
- $171.7M
- Net debt / EBITDA
- 2.20x
Liquidity9 / 20
Covers near-term obligations, without much room.
- Current assets
- $1.53B
- Current liabilities
- $1.26B
- Current ratio
- 1.21
Cash generation16 / 20
The business funds itself from operations.
- Operating cash flow
- $947.0M
- Free cash flow
- $644.7M
- FCF margin
- 8.4%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 66.6M
- Share growth (1y)
- -13.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
COKE Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jul 3, 2026 | Apr 3, 2026 | Dec 31, 2025 | Sep 26, 2025 | Jun 27, 2025 | Mar 28, 2025 |
| Revenue | 2.05 B | 1.85 B | 1.90 B | 1.89 B | 1.86 B | 1.58 B |
| Revenue Growth (YoY) | 10.61 % | 16.88 % | 9.03 % | 6.95 % | 3.32 % | -0.73 % |
| Cost of Revenue | 1.27 B | 1.12 B | 1.18 B | 1.14 B | 1.11 B | 952.87 M |
| Gross Profit | 778.41 M | 727.08 M | 727.53 M | 748.52 M | 742.50 M | 627.10 M |
| SG&A Expense | 507.07 M | 489.56 M | 482.02 M | 501.88 M | 470.41 M | 437.28 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 507.07 M | 489.56 M | 482.02 M | 501.88 M | 470.41 M | 437.28 M |
| Operating Income | 271.34 M | 237.52 M | 245.51 M | 246.63 M | 272.08 M | 189.82 M |
| Pretax Income | 215.12 M | 151.22 M | 188.22 M | 192.23 M | 252.99 M | 139.47 M |
| Tax Provision | 56.30 M | 39.66 M | 50.97 M | 49.90 M | 65.61 M | 35.86 M |
| Net Income | 158.82 M | 111.56 M | 137.25 M | 142.33 M | 187.39 M | 103.61 M |
| EPS (Basic) | 2.39 | 1.97 | 1.84 | 1.86 | 2.15 | 1.19 |
| EPS (Diluted) | 2.38 | 1.67 | 1.84 | 1.64 | 2.15 | 1.19 |
| Shares Outstanding | 66.56 M | 56.52 M | 73.66 M | 76.55 M | 76.97 M | 87.18 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.